-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics Sees FY2026 Sales $530.000M-$560.000M vs $632.367M Est

Benzinga·05/06/2026 20:44:20
Listen to the news
ADMA Biologics (NASDAQ:ADMA) sees FY2026 sales of $530.000 million-$560.000 million vs $632.367 million analyst estimate.